At the suckling-to-weaning transition, the shift in gut microbial metabolism (notably a rise in butyrate) contributes to maturation of the intestinal epithelial barrier, but sterile-supernatant and organoid experiments reproduce only part of the in vivo program. The open problem is to causally identify which individual metabolites or metabolite combinations, beyond butyrate, drive the transcriptional and functional changes of barrier maturation, deciphering the role played by each metabolite alone or in combination with others; to establish the cellular mechanisms involved, including the proposed but undemonstrated epigenetic routes (histone deacetylase inhibition, altered methyl-donor availability); to determine which regulations require the presence of live bacteria or are genetically encoded developmental programs versus which can be executed by epithelial exposure to metabolites alone; to control non-metabolite confounders in sterile-supernatant experiments; and to account for segment- and species-specific differences in the metabolite-epithelium relationships. As of 2026 the problem is partially advanced (beyond-butyrate metabolites with barrier effects in organoids, single-cell description of the weaning program, microbiome-driven epigenetic reprogramming at weaning) but its causal core remains unresolved.

Background

In mammals, the intestinal epithelium — a single layer of cells lining the gut — acts as a selective barrier between the lumen and the body. Its paracellular permeability (passage of molecules between adjacent cells) is governed by tight-junction proteins such as claudins, occludin and zonula occludens (CLDN, OCLN, TJP1), and barrier competence develops sharply during the suckling-to-weaning transition, when the young animal switches from maternal milk to solid food. This transition remodels the gut microbiota (the community of bacteria inhabiting the intestine) and its metabolic output: fermentation of plant-derived substrates raises short-chain fatty acids, in particular butyrate, and changes many other metabolites. Beaumont and colleagues studied this co-maturation in the suckling rabbit, combining in vivo measurements (microbiota composition, cecal metabolome, epithelial gene expression, Ussing chambers — an ex vivo device that measures electrical tissue resistance and permeability across living mucosa), and in vitro models: Caco-2 cells (a human colonocyte cell line that forms monolayers used to assay barrier formation) and intestinal organoids (self-organizing three-dimensional epithelial cultures derived from intestinal stem cells, which preserve cell-type diversity better than cell lines). They showed that sterile supernatant of cecal content taken after the onset of solid-food ingestion — a cell-free mixture of luminal metabolites — accelerated barrier formation in Caco-2 monolayers, with results pointing mainly to butyrate, and that the same supernatant reproduced in organoids only a subset of the gene regulations seen in vivo (e.g. the genes encoding angiogenin, the antimicrobial peptide beta-defensin-1, the microbial-lipopeptide receptor TLR2, and the tight-junction protein claudin-1), while others (epithelial differentiation, the IgA-secretion pathway) were not reproduced. Several metabolites whose concentrations change at weaning are known ligands of epigenetic machinery — butyrate and bacterial phenolic-acid derivatives inhibit histone deacetylases (HDACs, enzymes that compact chromatin and repress transcription), and intense bacterial conversion of choline to trimethylamine during exclusive suckling may drain methyl donors needed for DNA or histone methylation — making epigenetic remodeling a plausible but then-untested mechanistic route. Related background: the microbiome was shown to guide postnatal DNA-methylation programming of intestinal stem cells in suckling mice (Yu et al. 2015), and a microbiota-derived metabolite (inositol trisphosphate) was shown to activate epithelial HDAC3 and promote epithelial repair in adult mice (Wu et al. 2020), establishing metabolite-epigenetic axes in the gut that remain to be connected to the weaning-transition barrier program. Reviews of the epigenome-metabolome-microbiome axis and of organoid-based host-microbiota studies frame exactly these links as open (Amatullah & Jeffrey 2020; Bozzetti & Senger 2022).

Problem Statement

As stated by the source work and left unresolved: identify, causally, the microbiota-derived metabolites that drive intestinal epithelial barrier maturation at the suckling-to-weaning transition. Specifically, (1) decipher the role played by each individual metabolite beyond butyrate, alone or in combination with others at physiological concentrations and timing, in the in vivo transcriptional and functional changes of barrier maturation observed at the transition — given that metabolite-containing sterile cecal supernatant and butyrate in organoids reproduce only a subset of the in vivo regulations; (2) establish the cellular mechanisms by which these metabolites alter epithelial gene programs and barrier function, including or excluding the epigenetic routes proposed by the source (HDAC inhibition by butyrate and phenolic-acid derivatives, methyl-donor availability changes via choline catabolism); (3) determine which of the in vivo regulatory effects require the presence of live bacteria — potentially acting through immune, stromal, or systemic routes — or are genetically encoded developmental programs, and which can be executed solely by epithelial exposure to metabolite mixtures; (4) establish how far non-metabolite luminal components in sterile supernatants (e.g. endotoxin traces) contribute to observed effects, so that metabolite attribution is not confounded; and (5) assess how far the metabolite-epithelium relationships hold across intestinal segments and species, addressing the segment- and species-specific differences noted in the source literature.

Items (1)–(3) correspond to the three clauses of the title: the barrier-active metabolite(s), the cellular mechanism (including or excluding the proposed epigenetic routes), and the partition between epithelial-autonomous and live-bacteria- or developmental-program-dependent regulations. Items (4) and (5) bound any such causal attribution — (4) that it not rest on non-metabolite luminal components, and (5) how far it holds across intestinal segments and species.

References

  1. Beaumont M, Paës C, Mussard E, Knudsen C, Cauquil L, Aymard P, Barilly C, Gabinaud B, Zemb O, Fourre S, Gautier R, Lencina C, Eutamène H, Theodorou V, Canlet C, Combes S. Gut microbiota derived metabolites contribute to intestinal barrier maturation at the suckling-to-weaning transition. Gut Microbes 2020;11(5):1268–1286. DOI: 10.1080/19490976.2020.1747335. https://doi.org/10.1080/19490976.2020.1747335 (PMC7524271)
  2. Beaumont M, Mussard E, Barilly C, Lencina C, Gress L, Painteaux L, Gabinaud B, Cauquil L, Aymard P, Canlet C, Paës C, Knudsen C, Combes S. Developmental Stage, Solid Food Introduction, and Suckling Cessation Differentially Influence the Comaturation of the Gut Microbiota and Intestinal Epithelium in Rabbits. J Nutr 2022;152(3):723–736. DOI: 10.1093/jn/nxab411. https://doi.org/10.1093/jn/nxab411
  3. Cauquil L, Beaumont M, Schmaltz-Panneau B, Liaubet L, Lippi Y, Naylies C, Bluy L, Poli M, Gress L, Lencina C, Duranthon V, Combes S. Coprophagia in early life tunes expression of immune genes after weaning in rabbit ileum. Sci Rep 2024;14(1):8898. DOI: 10.1038/s41598-024-59591-6. https://doi.org/10.1038/s41598-024-59591-6
  4. Alberge J, Mussard E, Al-Ayoubi C, Lencina C, Marrauld C, Cauquil L, Achard CS, Mateos I, Alassane-Kpembi I, Oswald IP, Soler L, Combes S, Beaumont M. Butyrate reduces epithelial barrier dysfunction induced by the foodborne mycotoxin deoxynivalenol in cell monolayers derived from pig jejunum organoids. Gut Microbes 2024;16(1):2430424. DOI: 10.1080/19490976.2024.2430424. https://doi.org/10.1080/19490976.2024.2430424
  5. Beaumont M, Vicente CM, Plata-Calzado C, Lencina C, Jones E, Lecuelle S, Chalvon-Demersay T. The gut microbiota metabolite isovalerate enhances the epithelial barrier function in cell monolayers derived from porcine ileum organoids. Am J Physiol Gastrointest Liver Physiol 2026;330(4):G459–G477. DOI: 10.1152/ajpgi.00193.2025. https://doi.org/10.1152/ajpgi.00193.2025
  6. Malonga T, Knudsen C, Alberge J, Lhuillier E, Aymard P, Jones E, Lencina C, Despeyroux M, Riant E, Cabau C, Ivy A, Loving CL, Vialaneix N, Beaumont M. A Single-Cell Atlas of Transcriptome Changes in the Intestinal Epithelium at the Suckling-to-Weaning Transition in Male Rabbits. Cell Mol Gastroenterol Hepatol 2026;20(1):101628. DOI: 10.1016/j.jcmgh.2025.101628. https://doi.org/10.1016/j.jcmgh.2025.101628
  7. Yang L, Peery RC, Zhou S, Chen X, Farmer LM, Gutierrez F, Fowler S, Zhang L, Salamat JM, Riggins K, Shi J, Shen L. Weaning drives microbiome-mediated epigenetic regulation to shape immune memory in mice. Nat Microbiol 2026;11(4):1064–1079. DOI: 10.1038/s41564-026-02295-6. https://doi.org/10.1038/s41564-026-02295-6
  8. Yu DH, Gadkari M, Zhou Q, Yu S, Gao N, Guan Y, Schady D, Roshan TN, Chen MH, Laritsky E, Ge Z, Wang H, Chen R, Westwater C, Bry L, Waterland RA, Moriarty C, Hwang C, Swennes AG, Moore SR, Shen L. Postnatal epigenetic regulation of intestinal stem cells requires DNA methylation and is guided by the microbiome. Genome Biol 2015;16:211. DOI: 10.1186/s13059-015-0763-5. https://doi.org/10.1186/s13059-015-0763-5
  9. Wu SE, Hashimoto-Hill S, Woo V, Eshleman EM, Whitt J, Engleman L, Karns R, Denson LA, Haslam DB, Alenghat T. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature 2020;586(7827):108–112. DOI: 10.1038/s41586-020-2604-2. https://doi.org/10.1038/s41586-020-2604-2
  10. Lee H, Jung KB, Kwon O, Son YS, Choi E, Yu WD, Son N, Jeon JH, Jo H, Yang H, Son YR, Yun CS, Cho HS, Kim SK, Kim DS, Park DS, Son MY. Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice. Gut Microbes 2022;14(1):2121580. DOI: 10.1080/19490976.2022.2121580. https://doi.org/10.1080/19490976.2022.2121580
  11. Zhang Y, Hu Q, Zeng X, Yin L, Tang Y, Wang Q, Huang J, Li J, Yang H. Intestinal organoid screen reveals that Bacillus velezensis PGM541 promotes epithelial proliferation via its metabolite butyric acid. Microbiome 2026;14(1):116. DOI: 10.1186/s40168-026-02346-4. https://doi.org/10.1186/s40168-026-02346-4
  12. Amatullah H, Jeffrey KL. Epigenome-metabolome-microbiome axis in health and IBD. Curr Opin Microbiol 2020;56:97–108. DOI: 10.1016/j.mib.2020.08.005. https://doi.org/10.1016/j.mib.2020.08.005
  13. Bozzetti V, Senger S. Organoid technologies for the study of intestinal microbiota-host interactions. Trends Mol Med 2022;28(4):290–303. DOI: 10.1016/j.molmed.2022.02.001. https://doi.org/10.1016/j.molmed.2022.02.001